Clinical and laboratory management of patients under oral anticoagulation;Avaliacao clinica e laboratorial de pacientes em uso de anticoagulantes orais

Arquivos Brasileiros de Cardiologia

Volumn 68, Issue 5, 1997, Pages 353-356

  Lourenço, Dayse Maria ^a,b   Lopes, Letícia Helena Caldas ^a   Vignal, Carla Valadares ^a   Marelli, Vânia Maria ^a  

^a Hematol Hemoterapia da Univ F   (Brazil)

^b NONE   (Brazil)

Author keywords

International normalized ratio; Oral anticoagulation; Thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; PHENINDIONE; PHENPROCOUMON; VITAMIN K GROUP; WARFARIN;

ANTICOAGULATION; ARTERY OCCLUSION; ARTICLE; BLEEDING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PROTHROMBIN TIME; THROMBOEMBOLISM; TREATMENT FAILURE; TREATMENT PLANNING; ADOLESCENT; ADULT; AGED; BLOOD CLOTTING; DRUG ANTAGONISM; DRUG EFFECT; MIDDLE AGED; RETROSPECTIVE STUDY;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD COAGULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTHROMBIN TIME; RETROSPECTIVE STUDIES; THROMBOEMBOLISM; VITAMIN K;

EID: 0031129330     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Hirsh J, Fuster V - Guide to anticoagulant therapy. Part 2 Oral anticoagulants. Circulation 1994, 89 1469-80
2. Stults BM, Dere WH, Caine TH - Long-term anticoagulation. Indications and management Western J Med 1989, 151 414-29.
3. Thijssen HHW, Drittij-Reijinders MJ - Vitamin K metabolism and vitamin K1 status in human liver samples: a search for inter-individual differences in warfarin sensitivity Br J Haematol 1993; 84: 681-5.
4. Loeliger EA, Poller L, Samama MM et al - Questions and answers on prothrombin time standardization in oral anticoagulant control. Thrombos Haemost 1985; 54: 515-7.
5. Lourenço DM, Alves EC - Controle laboratorial da anticoagulação oral Rev Assoc Méd Bras 1994, 41 (2) 103-8
6. Quick AJ, Stanley-Brown M, Bancroft FW - A study of the coagulation defect in hemophilia and in jaundice Am J Med Sci 1935, 190: 601-11
7. Morley J, Marinchak R, Rials SJ, Kowey P - Atrial fibrillation, anticoagulation, and stroke Am J Cardiol 1996; 77 38A-44A
8. Preston FE - Quality control and oral anticoagulation. Thrombos Haemost 1995, 74: 515-20
9. Galloway MJ, Foggin JJ, Dixon S - Introduction of computer assisted control of oral anticoagulation in general practice J Clin Pathol 1995; 48. 1144-6
10. van der Besselar AHP, van der Meer FJM, Gerrits-Drabbe CW - Therapeutic control of oral anticoagulant treatment in the Netherlands Am J Clin Pathol 1988, 90: 685-90
11. Barbui T, Finazzi G, Remozzi A - Clinical coagulation laboratory and oral anticoagulant therapy treatment. Instrumentation and methodology Thrombos Haemost 1995; 74: 511-4.
12. Cazaux V, Gauthier B, Elias A et al - Predicting daily maintenance dose of fluindione, an oral anticoagulant drug Thrombos Haemost 1996; 75: 731-3
13. Pattacini C, Manotti C, Pini M, Quintavalla R, Dettori AG - A comparative study on the quality of oral anticoagulant therapy (warfarin versus acenocoumarol) Thrombos Haemost 1994, 71: 188-91
14. Karlson B, Leijd B, Hellstrom K-On the influence of vitamin K-nch vegetables and wine on the effectiveness of warfarin therapy Acta Med Scand 1986; 220: 347-50
15. Landefeld CS, Beyth RJ - Anticoagulant-related bleeding clinical epidemiology, prediction, and prevention Am J Med 1993, 95. 315-28.
16. van der Meer FJ, Rosendaal FR, Vandenbroucke JP, Briet E - Bleeding complications in oral anticoagulant therapy. An analysis of risk factors Arch Intern Med 1993; 153. 1557-62